Clinical trial / 2014
Maternal DHA supplementation reduced risk of lower neurodevelopment scores in infants.
A randomized trial evaluated 270 pregnant women receiving 400 mg/day DHA or placebo from 16 weeks gestation to delivery. Infants in the placebo group had increased risk of poorer language scores at 14 months (words understood OR 3.22, CL 1.49-6.94; words produced OR 2.61, CL 1.22-5.58) and 18 months, as well as lower visual acuity at 2 months (OR 2.69, CL 1.10-6.54).
NANO COUNTERPOINT
On fish and fish oil
We keep this study as published. Here is the other evidence behind NANO's stance.
- A meta-analysis of 10 trials with 77,917 people found omega-3 supplements had no significant association with fatal or nonfatal coronary heart disease or major vascular events.Aung T, Halsey J, Kromhout D et al. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. JAMA cardiology, 2018. PMID 29387889
- A Cochrane review concluded that moderate- and high-quality evidence suggests more EPA and DHA has little or no effect on mortality or cardiovascular health, with earlier suggested benefits coming from trials at higher risk of bias. Low-quality evidence suggested plant omega-3 (ALA) may slightly reduce cardiovascular event risk.Abdelhamid AS, Brown TJ, Brainard JS et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. The Cochrane database of systematic reviews, 2018. PMID 30019766
- For people who want long-chain omega-3s without fish, a review found algae-based DHA raised blood DHA levels.Lane K, Derbyshire E, Li W et al. Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature. Critical reviews in food science and nutrition, 2014. PMID 24261532
- Study type
- Randomized controlled trial
- Who was studied
- 270 pregnant women and their term infants
- What was measured
- Infant neurodevelopment and visual acuity
THE PAPER
Omega-3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy.
Mulder KA, King DJ, Innis SM. PLoS One, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.